Form 4 for ABUS Arbutus Biopharma Corp
Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-01 · accession 0001447028-21-000068 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-03 | 2021-12-01 | ABUS | Sofia Michael J. | CSO | S - Sale | $5.09 | -200.0K | 1.30M | -13% | -$1.02M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2021-12-01 | S | D | 200,000 | $5.09 | 1,303,403 | D | — | — |